Optimizing clinical trials in real-time with Truveta

Clinical trial execution risk often begins long before first patient enrolled. Protocols are finalized without validating assumptions against contemporary care delivery. Site selection relies on historical performance rather than current patient availability. Post-trial evidence strategies require new infrastructure and fragmented workflows.

This whitepaper examines how Truveta enables sponsors to optimize trial planning, enrollment, and follow-up with daily refreshed, longitudinal, nationally representative real-world data.